How the sympathetic (fight-or-flight) system works in adults with Down syndrome
Official title: Dysautonomia InVestigation in Individuals With Down SyndromE: DIVE Study
Run by University of Colorado, Denver · NCT07238465 · Data updated 2026-11-12
This study will test how the sympathetic nervous system responds to stressors like exercise, cold, pain, fear, and caffeine in adults with Down syndrome to see if their heart rate and blood pressure responses are reduced or altered.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | April 6, 2026 |
| Main results expected | December 2029 |
| Study ends | December 2030 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT07238465 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with Down syndrome aged 18–50 who are apparently healthy (no recent cardiovascular/pulmonary/inflammatory/metabolic disease), euthyroid or on a stable thyroid dose, have BMI below 45 kg/m2, can tolerate repeated blood draws and catheter placement, and can bring a study partner to all visits.
✕Probably not a fit
People taking heart-rate–altering medications, with uncontrolled hypertension or hypotension, recent cancer, active cardiovascular disease, or who cannot tolerate blood draws or travel to the site are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 3 interventional study will provoke sympathetic activation in adults with Down syndrome using standardized stressors including exercise, cold exposure, pain stimuli, fear responses, and caffeine. Investigators will record beat-to-beat heart rate and blood pressure, collect blood samples for catecholamine measurements, and use catheter-based monitoring when needed. Eligible participants are adults 18–50 years old without recent cardiovascular, pulmonary, inflammatory, or metabolic disease and must tolerate repeated blood draws and procedures after a 12-hour fast. Data will be compared to expected physiological responses to characterize whether sympathetic responses are blunted or otherwise different in this population.
Why it matters
Potential benefit: If successful, the study could identify specific autonomic deficits in people with Down syndrome that guide targeted interventions to improve exercise tolerance and reduce cardiovascular risk.
How similar studies have gone: Small prior studies have reported blunted maximal heart-rate responses to exercise in Down syndrome, but comprehensive testing of sympathetic responses across multiple stressors is largely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-50 yrs old and apparently healthy individuals * Ability to understand the study and give assent to participate * Has a study partner who can attend all visits for the individuals with DS, and answer questionnaires, provide consent when necessary * Corrected or non-existent congenital heart disease * Euthyroid or on stable thyroid medication dose for at least 6 months * Free from cardiovascular, pulmonary, inflammatory, or metabolic disease in the past 6 months that would prevent participation in study procedures * BMI \<45kg/m2 * Ability to tolerate repeated blood draws / catheter placement Exclusion Criteria: * Hypertension (resting systolic blood pressure \[SBP\] ≥140 and/or diastolic blood pressure \[DBP\] ≥90 mmHg) this includes those on medications to treat hypertension * Hypotension (resting BP of \<90/60 mmHg) * Cancer in the last six months * Any heart-rate-altering medications or any other medication that may modify metabolic responses * Self-reported diabetes or use of glucose-lowering medication * Tobacco products, including vaping, or marijuana use * Currently pregnant * Post-menopausal women Specific Exclusion Criteria for Certain Stressors: * Orthopedic limitations that would prohibit exercise or movement for exercise * Fracture of limb to be immersed for CPT * Open cut or sore on hand to be immersed for CPT * Raynaud's syndrome for CPT
Where it's running
-
Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States Recruiting
Study contacts
- Study coordinator: Sara R Sherman, PhD
- Email: sara.r.sherman@cuanschutz.edu
- Phone: 303-724-0598
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if small fiber neuropathy is common in people with primary Sjögren’s syndrome
This study tests whether small fiber neuropathy is common in adults with primary Sjögren’s syndrome using a quick, non-invasive Sudoscan test.
-
Kinematic analysis of hand and arm movement in kids with Down syndrome, CP and healthy children
This study tests how well an instrumented Box and Block Test and motion tracking can measure upper-limb movement in healthy kids and those with pyramidal hemisyndrome or Down syndrome.
-
Understanding how ADT for prostate cancer may raise blood pressure and whether nerves or kidneys are involved
This study tests whether nervous system or kidney dysfunction contributes to high blood pressure in men receiving androgen deprivation therapy for prostate cancer.
-
Sensory integration to help balance and movement in kids with Down syndrome
Aimed at seeing if adding sensory integration to physical therapy helps improve gross motor skills and balance in children with Down syndrome.
-
Collaboration for Down Syndrome Progress (CDP) in people with Down syndrome
A long-term study following people with Down syndrome of all ages to see how health and everyday life change over time.
-
JAK inhibitor treatment for Down syndrome in children and young adults
This study tests whether 6 months of tofacitinib can help improve safety and neurodevelopment in people with Down syndrome aged 6 to 22, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.